In human intestinal epithelial and T cell lines, nanomolar KPV inhibited NF-kappaB and MAP kinase activation, and oral KPV reduced the incidence of DSS- and TNBS-induced colitis in mice alongside lower pro-inflammatory cytokine expression.
Dalmasso G et al., Gastroenterology 2008






